Structure-based, multi-targeted drug discovery approach to eicosanoid inhibition: Dual inhibitors of

Ho, Joseph D.; Lee, Matthew R.; Rauch, Charles T.; Aznavour, Kristen; Park, Jonathan S.; Luz, John G.; Antonysamy, Stephen; Condon, Bradley; Maletic, Milan; Zhang, Aiping; Hickey, Michael J.; Hughes, Norman E.; Chandrasekhar, Srinivasan; Sloan, Ashley V.; Gooding, Karen; Harvey, Anita; Yu, Xiao-Peng; Kahl, Steven D.; Norman, Bryan H.

doi:10.1016/j.bbagen.2020.129800

Structure-based, multi-targeted drug discovery approach to eicosanoid inhibition: Dual inhibitors of

Journal Article · 01 February 2021 · BBA - General Subjects

DOI:https://doi.org/10.1016/j.bbagen.2020.129800· OSTI ID:1767217

Ho, Joseph D.; Lee, Matthew R.; Rauch, Charles T.; Aznavour, Kristen; Park, Jonathan S.; Luz, John G.; Antonysamy, Stephen; Condon, Bradley; Maletic, Milan; Zhang, Aiping; Hickey, Michael J.; Hughes, Norman E.; Chandrasekhar, Srinivasan; Sloan, Ashley V.; Gooding, Karen; Harvey, Anita; Yu, Xiao-Peng; Kahl, Steven D.; Norman, Bryan H.

Research Organization:: Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)

Sponsoring Organization:: DOE - Office Of Science; INDUSTRY

OSTI ID:: 1767217

Journal Information:: BBA - General Subjects, Journal Name: BBA - General Subjects Journal Issue: (2) Vol. 1865

Country of Publication:: United States

Language:: ENGLISH

References (39)

Discovery of Novel 5-Lipoxygenase-Activating Protein (FLAP) Inhibitors by Exploiting a Multistep Virtual Screening Protocol Olgac, Abdurrahman; Carotti, Andrea; Kretzer, Christian Journal of Chemical Information and Modeling, Vol. 60, Issue 3 https://doi.org/10.1021/acs.jcim.9b00941	journal	February 2020
5-Lipoxygenase-Activating Protein (FLAP) Inhibitors. Part 4: Development of 3-[3- tert -Butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1 H -indol-2-yl]-2,2-dimethylpropionic Acid (AM803), a Potent, Oral, Once Daily FLAP Inhibitor Stock, Nicholas S.; Bain, Gretchen; Zunic, Jasmine Journal of Medicinal Chemistry, Vol. 54, Issue 23 https://doi.org/10.1021/jm2008369	journal	December 2011
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology Funk, C. D. Science, Vol. 294, Issue 5548 https://doi.org/10.1126/science.294.5548.1871	journal	November 2001
Bioinformatic and enzymatic characterization of the MAPEG superfamily: Characterization of MAPEG members Bresell, Anders; Weinander, Rolf; Lundqvist, Gerd FEBS Journal, Vol. 272, Issue 7 https://doi.org/10.1111/j.1742-4658.2005.04596.x	journal	March 2005
Characterization of Microsomal Prostaglandin E Synthase 1 Inhibitors Korotkova, Marina; Jakobsson, Per-Johan Basic & Clinical Pharmacology & Toxicology, Vol. 114, Issue 1 https://doi.org/10.1111/bcpt.12162	journal	November 2013
The Minimum Significant Ratio: A Statistical Parameter to Characterize the Reproducibility of Potency Estimates from Concentration-Response Assays and Estimation by Replicate-Experiment Studies Eastwood, Brian J.; Farmen, Mark W.; Iversen, Philip W. Journal of Biomolecular Screening, Vol. 11, Issue 3 https://doi.org/10.1177/1087057105285611	journal	April 2006
Discovery and Early Clinical Development of an Inhibitor of 5-Lipoxygenase Activating Protein (AZD5718) for Treatment of Coronary Artery Disease Pettersen, Daniel; Broddefalk, Johan; Emtenäs, Hans Journal of Medicinal Chemistry, Vol. 62, Issue 9 https://doi.org/10.1021/acs.jmedchem.8b02004	journal	March 2019
Discovery and characterization of [(cyclopentyl)ethyl]benzoic acid inhibitors of microsomal prostaglandin E synthase-1 Partridge, Katherine M.; Antonysamy, Stephen; Bhattachar, Shobha N. Bioorganic & Medicinal Chemistry Letters, Vol. 27, Issue 6 https://doi.org/10.1016/j.bmcl.2016.11.011	journal	March 2017
Crystal structure of microsomal prostaglandin E2 synthase provides insight into diversity in the MAPEG superfamily Sjogren, T.; Nord, J.; Ek, M. Proceedings of the National Academy of Sciences, Vol. 110, Issue 10 https://doi.org/10.1073/pnas.1218504110	journal	February 2013
Identification of multi-target inhibitors of leukotriene and prostaglandin E2 biosynthesis by structural tuning of the FLAP inhibitor BRP-7 Gür, Zehra Tuğçe; Çalışkan, Burcu; Garscha, UIrike European Journal of Medicinal Chemistry, Vol. 150 https://doi.org/10.1016/j.ejmech.2018.03.045	journal	April 2018
Initial Clinical Experience with AZD5718, a Novel Once Daily Oral 5-Lipoxygenase Activating Protein Inhibitor: Initial Clinical Experience with AZD5718 Ericsson, Hans; Nelander, Karin; Lagerstrom-Fermer, Maria Clinical and Translational Science, Vol. 11, Issue 3 https://doi.org/10.1111/cts.12546	journal	March 2018
Crystallizing Membrane Proteins in the Lipidic Mesophase. Experience with Human Prostaglandin E2 Synthase 1 and an Evolving Strategy Li, Dianfan; Howe, Nicole; Dukkipati, Abhiram Crystal Growth & Design, Vol. 14, Issue 4 https://doi.org/10.1021/cg500157x	journal	March 2014
Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function Cheng, Y. Journal of Clinical Investigation, Vol. 116, Issue 5 https://doi.org/10.1172/JCI27540	journal	May 2006
Prostanoids in health and disease: Fig. 1. Smyth, Emer M.; Grosser, Tilo; Wang, Miao Journal of Lipid Research, Vol. 50, Issue Supplement https://doi.org/10.1194/jlr.R800094-JLR200	journal	December 2008
Crystal Structure of Inhibitor-Bound Human 5-Lipoxygenase-Activating Protein Ferguson, A. D.; McKeever, B. M.; Xu, S. Science, Vol. 317, Issue 5837 https://doi.org/10.1126/science.1144346	journal	July 2007
Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI Raynauld, J-P; Martel-Pelletier, J.; Bias, P. Annals of the Rheumatic Diseases, Vol. 68, Issue 6 https://doi.org/10.1136/ard.2008.088732	journal	July 2008
Targeting biosynthetic networks of the proinflammatory and proresolving lipid metabolome Werner, Markus; Jordan, Paul M.; Romp, Erik The FASEB Journal, Vol. 33, Issue 5 https://doi.org/10.1096/fj.201802509R	journal	February 2019
BRP-187: A potent inhibitor of leukotriene biosynthesis that acts through impeding the dynamic 5-lipoxygenase/5-lipoxygenase-activating protein (FLAP) complex assembly Garscha, Ulrike; Voelker, Susanna; Pace, Simona Biochemical Pharmacology, Vol. 119 https://doi.org/10.1016/j.bcp.2016.08.023	journal	November 2016
Crystal Structures of mPGES-1 Inhibitor Complexes Form a Basis for the Rational Design of Potent Analgesic and Anti-Inflammatory Therapeutics Luz, John Gately; Antonysamy, Stephen; Kuklish, Steven L. Journal of Medicinal Chemistry, Vol. 58, Issue 11 https://doi.org/10.1021/acs.jmedchem.5b00330	journal	May 2015
Risk of Cardiovascular Events Associated With Selective COX-2 Inhibitors Mukherjee, Debabrata JAMA, Vol. 286, Issue 8 https://doi.org/10.1001/jama.286.8.954	journal	August 2001
Identification and Characterization of Novel Microsomal Prostaglandin E Synthase-1 Inhibitors for Analgesia Chandrasekhar, S.; Harvey, A. K.; Yu, X. -P. Journal of Pharmacology and Experimental Therapeutics, Vol. 356, Issue 3 https://doi.org/10.1124/jpet.115.228932	journal	January 2016
Prostaglandins and Inflammation Ricciotti, Emanuela; FitzGerald, Garret A. Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 31, Issue 5 https://doi.org/10.1161/ATVBAHA.110.207449	journal	May 2011
Leukotrienes Peters-Golden, Marc; Henderson, William R. New England Journal of Medicine, Vol. 357, Issue 18 https://doi.org/10.1056/NEJMra071371	journal	November 2007
The membrane organization of leukotriene synthesis Mandal, A. K.; Skoch, J.; Bacskai, B. J. Proceedings of the National Academy of Sciences, Vol. 101, Issue 17 https://doi.org/10.1073/pnas.0308523101	journal	April 2004
Dual Acting Anti-Inflammatory Drugs Leone, S.; Ottani, A.; Bertolini, A. Current Topics in Medicinal Chemistry, Vol. 7, Issue 3 https://doi.org/10.2174/156802607779941341	journal	February 2007
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A2 Cheng, Y. Science, Vol. 296, Issue 5567 https://doi.org/10.1126/science.1068711	journal	April 2002
Effects of a FLAP inhibitor, GSK2190915, in asthmatics with high sputum neutrophils Chaudhuri, R.; Norris, V.; Kelly, K. Pulmonary Pharmacology & Therapeutics, Vol. 27, Issue 1 https://doi.org/10.1016/j.pupt.2013.11.007	journal	February 2014
Discovery and Characterization of 2-Acylaminoimidazole Microsomal Prostaglandin E Synthase-1 Inhibitors Schiffler, Matthew A.; Antonysamy, Stephen; Bhattachar, Shobha N. Journal of Medicinal Chemistry, Vol. 59, Issue 1 https://doi.org/10.1021/acs.jmedchem.5b01249	journal	December 2015
Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886 Riendeau, Denis; Aspiotis, Renee; Ethier, Diane Bioorganic & Medicinal Chemistry Letters, Vol. 15, Issue 14 https://doi.org/10.1016/j.bmcl.2005.05.027	journal	July 2005
Encapsulation of the dual FLAP/mPEGS-1 inhibitor BRP-187 into acetalated dextran and PLGA nanoparticles improves its cellular bioactivity Shkodra-Pula, Blerina; Kretzer, Christian; Jordan, Paul M. Journal of Nanobiotechnology, Vol. 18, Issue 1 https://doi.org/10.1186/s12951-020-00620-7	journal	May 2020
Licofelone--clinical update on a novel LOX/COX inhibitor for the treatment of osteoarthritis Alvaro-Gracia, J. M. Rheumatology, Vol. 43, Issue 90001 https://doi.org/10.1093/rheumatology/keh105	journal	February 2004
Discovery of the first dual inhibitor of the 5-lipoxygenase-activating protein and soluble epoxide hydrolase using pharmacophore-based virtual screening Temml, Veronika; Garscha, Ulrike; Romp, Erik Scientific Reports, Vol. 7, Issue 1 https://doi.org/10.1038/srep42751	journal	February 2017
Licofelone-A Novel Analgesic and Anti-Inflammatory Agent Kulkarni, S.; Pal Singh, Vijay Current Topics in Medicinal Chemistry, Vol. 7, Issue 3 https://doi.org/10.2174/156802607779941305	journal	February 2007
The molecular mechanism of the inhibition by licofelone of the biosynthesis of 5-lipoxygenase products: Licofelone and 5-lipoxygenase product synthesis Fischer, L.; Hornig, M.; Pergola, C. British Journal of Pharmacology, Vol. 152, Issue 4 https://doi.org/10.1038/sj.bjp.0707416	journal	October 2007
Licofelone Suppresses Prostaglandin E ₂ Formation by Interference with the Inducible Microsomal Prostaglandin E ₂ Synthase-1 Koeberle, Andreas; Siemoneit, Ulf; Bühring, Ulrike Journal of Pharmacology and Experimental Therapeutics, Vol. 326, Issue 3 https://doi.org/10.1124/jpet.108.139444	journal	June 2008
The eicosanoids and their biochemical mechanisms of action Smith, W. L. Biochemical Journal, Vol. 259, Issue 2 https://doi.org/10.1042/bj2590315	journal	April 1989
Dynamic eicosanoid responses upon different inhibitor and combination treatments on the arachidonic acid metabolic network He, Chong; Wu, Yiran; Lai, Yongquan Molecular BioSystems, Vol. 8, Issue 5 https://doi.org/10.1039/c2mb05503a	journal	January 2012
The Coxibs, Selective Inhibitors of Cyclooxygenase-2 FitzGerald, Garret A.; Patrono, Carlo New England Journal of Medicine, Vol. 345, Issue 6 https://doi.org/10.1056/NEJM200108093450607	journal	August 2001
Biosynthesis and metabolism of leukotrienes Murphy, Robert C.; Gijón, Miguel A. Biochemical Journal, Vol. 405, Issue 3 https://doi.org/10.1042/BJ20070289	journal	July 2007

Similar Records

Structure-based, multi-targeted drug discovery approach to eicosanoid inhibition: Dual inhibitors of mPGES-1 and 5-lipoxygenase activating protein (FLAP)

Journal Article · 2021 · Biochimica et Biophysica Acta - General Subjects · OSTI ID:1809376

Discovery of the Highly Potent PI3K/mTOR Dual Inhibitor PF-04979064 through Structure-Based Drug Design

Journal Article · 2012 · ACS Medicinal Chemistry Letters · OSTI ID:1495455

Discovery of potent, reversible MetAP2 inhibitors via fragment based drug discovery and structure based drug design—Part 2

Journal Article · 2016 · Bioorganic and Medicinal Chemistry Letters · OSTI ID:1358849

Structure-based, multi-targeted drug discovery approach to eicosanoid inhibition: Dual inhibitors of

Citation Formats

References (39)

Similar Records

Related Subjects